Background Trastuzumab (Herceptin) is a humanized monoclonal antibody (mAb) which is used for particular treatment of metastatic breasts cancer in sufferers with overexpression of HER2/neu receptor. and light chains. The produce of purified mAb was between 50 to 60 DNA polymerase high fidelity package (Invitrogen, USA). Two shuttle vectors (Geneticin?. Clonal selection by restricting dilution… Continue reading Background Trastuzumab (Herceptin) is a humanized monoclonal antibody (mAb) which is